unknown
Stage
1
Investors
About
Dicerna Pharmaceuticals develops RNA interference (RNAi) therapeutics to treat rare and prevalent diseases by silencing disease-causing genes.
Explore Dicerna Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.